Novosti
Khirurgii
This journal is
indexed in Scopus



Year 2018 Vol. 26 No 2

GENERAL & SPECIAL SURGERY

DOI: https://dx.doi.org/10.18484/2305-0047.2018.2.155   |  

I.A. SANETS ¹, A.E. SILIN ¹, YU.I. YARETS ¹, V.V. ANICHKIN ²

GENETIC MARKERS OF VENOUS THROMBOEMBOLISM IN SURGICAL PATIENTS

The Republican Research Centre for Radiation Medicine and Human Ecology 1,
Gomel State Medical University2, Gomel
The Republic of Belarus

Objective. o study the occurrence of genetic markers of the venous thromboembolism (FV:G1691A, FII:G20210A, MTHFR:C677T and PAI-1:5G/4G) in patients who have previously had deep vein thrombosis and/or the pulmonary embolism as well as in surgical patients without phlebothrombosis episodes in the anamnesis.
Methods. The subjects of the study were patients (n=54) suffering from cholelithiasis. All individuals were divided into two groups: group 1 consisted of patients with deep vein thrombosis and/or pulmonary embolism in the past (n=29, 12 males and 17 females, the mean age of patients was 59.412.4 years). The second group was presented by patients without venous thromboembolism in the case history (n=25, 9 males and 16 females, the mean age 54.78.4 years). The molecular genetic testing of four main factors associated with a predisposition to thrombotic complications (FV:G1691A, FII:G20210A, MTHFR:C677T and PAI-1:5G/4G) was performed in patients of both groups. The study was carried out using the PCR method with three different oligonucleotide primers to identify each genetic polymorphism (mutation).
Results. The incidence of Leiden mutation (FV:G1691A) in the surgical patients with the venous thromboembolism was significantly higher than in patients without phlebothrombosis episodes in the past (25% and 4%, respectively, =0.038).
There were no significant differences between the groups of patients with the venous thrombotic complications and in the control group patients in terms of others genetic polymorphism: FII: G20210A (=0.349), PAI-1: 5G/4G (=0.751) and MTHFR: C677T (=0.416).
Conclusions. The presence of the Leiden mutation of the V coagulation factor in surgical patients significantly increases the risk of thrombotic complications in the postoperative period. The presence of FII:G20210A, PAI-1:5G/4G, MTHFR:C677T genetic defects in surgical patients are not associated with the likelihood of the postoperative thrombosis development.

Keywords: venous thromboembolism, Leiden mutation, prothrombin, methylene tetrahydrofolate reductase, inhibitor of plasminogen activation
p. 155-162 of the original issue
References
  1. Klinicheskii protokol lecheniia i profilaktiki venoznoi trombembolii: Prikaz M-va zdravookhraneniia Resp Belarus 150; 14.02.2011 [Elektronnyi resurs]. 2011 [Data dostupa: 12.12.2016]. Available from: http://minzdrav.gov.by/ru/static/spavochno-infirm/protololy_lechenia/protokoly_2011 (in Riss.)
  2. Beloenko ED, Volosheniuk AN, Boltrukevich SI, Prasmytskii OT, Bogomolov AN, Eismont OL, Iliasevich IA, Mavrichev SA. Profilaktika i lechenie tromboembolicheskikh oslozhnenii v travmatologii i ortopedii: prakt posobie. Minsk, RB: V.I.Z.A. Grupp; 2006. 171 p. (in Russ.)
  3. Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol. 1997 Jul;34(3):171-87.
  4. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation. 2010 May 4;121(17):1896-903. doi: 10.1161/CIRCULATIONAHA.109.921460.
  5. Arnoud E, Reny JL, Emmerich J, Aiach M. Thrombose veineuse et anomalies génétiques de lhémostase. Sang Thrombose Vaisseaux. 2000;12(7):426-32.
  6. Meltzer ME, Lisman T, de Groot PG, Meijers JC, le Cessie S, Doggen CJ, Rosendaal FR. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood. 2010 Jul 8;116(1):113-21. doi: 10.1182/blood-2010-02-267740.
  7. Jusić-Karić A, Terzić R, Jerkić Z, Avdić A, Podanin M. Frequency and association of 1691 (G>A) FVL, 20210 (G>A) PT and 677 (C>T) MTHFR with deep vein thrombosis in the population of Bosnia and Herzegovina. Balkan J Med Genet. 2016 Aug 2;19(1):43-50. eCollection 2016 Jul 1.
  8. Caprini JA, Glase CJ, Anderson CB, Hathaway K. Laboratory markers in the diagnosis of venous thromboembolism. Circulation. 2004 Mar 30;109(12 Suppl 1):14-18. doi: 10.1161/01.CIR.0000122869.59485.36.
  9. Hosseini S, Kalantar E, Hosseini MS, Tabibian S, Shamsizadeh M, Dorgalaleh A. Genetic risk factors in patients with deep venous thrombosis, a retrospective case control study on Iranian population. Thromb J. 2015 Nov 10;13:35. doi: 10.1186/s12959-015-0064-y. eCollection 2015.
  10. Miranda-Vilela AL. Role of polymorphisms in factor V (FV Leiden), prothrombin, plasminogen activator inhibitor type-1 (PAI-1), methylenetetrahydrofolate reductase (MTHFR) and cystathionineβ-synthase (CBS) genes as risk factors for thrombophilias. Mini Rev Med Chem. 2012 Sep 1;12(10):997-1006. doi: 10.2174/138955712802762338.
  11. Glueck CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, Sieve-Smith L, Tracy T. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism. 2000 Jul;49(7):845-52. doi: 10.1053/meta.2000.6749.
  12. Gipergomotsisteinemiia kak etiologicheskii faktor reproduktivnoi nedostatochnosti pri trombofilii [Elektronnyi resurs]. 2017 [Data dostupa: 25.02.2017]. Available from: http://newlab-med.ru/vracham/poleznaya-informacziya/gipergomoczisteinemiya-kak-etiologicheskij-faktor-reproduktivnoj-nedostatochnosti-pri-trombofilii.html (in Russ.)
  13. Lee YH, Song GG. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:8-14. doi: 10.1016/j.ejogrb.2013.12.030.
  14. Strandberg K, Stenflo J, Nilsson C, Svensson PJ. APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden. J Thromb Haemost. 2005 Nov;3(11):2578-80. doi: 10.1111/j.1538-7836.2005.01617.x.
  15. Isordia-Salas I, Leaños-Miranda A, Sainz IM, Reyes-Maldonado E, Borrayo-Sánchez G. Association of the plasminogen activator inhibitor-1 gene 4G/5G polymorphism with ST elevation acute myocardial infarction in young patients. Rev Esp Cardiol. 2009 Apr;62(4):365-72. doi: 10.1016/S1885-5857(09)71663-9. [Article in English, Spanish]
Address for correspondence:
246040, The Republic of Belarus,
Gomel, Ilyich Str., 290,
Republican Scientific Center
for Radiation Medicine and Human Ecology,
Surgical Unit of the Consultative Polyclinic,
Tel. office: +375-232-38 96 36,
e-mail: igor-sanets@yandex.ru,
Sanets Igor A.
Information about the authors:
Sanets Igor A., Surgeon, Surgical Unit of the Consultative Polyclinic, the Republican Scientific Center for Radiation Medicine and Human Ecology, Gomel, Republic of Belarus.
http://orcid.org/0000-0001-5777-3416
Yarets Yuliya I., PhD, Associate Professor, Head of the Clinical and Diagnostic Laboratory, the Republican Scientific Center for Radiation Medicine and Human Ecology, Gomel, Republic of Belarus.
http://orcid.org/0000-0001-8879-5079
Silin Arkadij E., PhD, Head of the Laboratory of Molecular Genetics, the Republican Scientific Center for Radiation Medicine and Human Ecology, Gomel, Republic of Belarus.
http://orcid.org/0000-0003-2387-554x
Anichkin Vladimir V., MD, Professor, Professor of the Department of Surgical Diseases 3 with the Course of Urology, Gomel State Medical University, Gomel, Republic of Belarus.
http://orcid.org/0000-0002-9022-5320
Contacts | ©Vitebsk State Medical University, 2007